Yunkang Group Limited
Research Yunkang Group Limited (2325.HK) on Bullrun: market cap HKD 342.43M, P/E 5.3. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker2325.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyHKD
- Market capHKD 342.43M
- P/E5.3
- Financial periodFY2025
- RevenueCNY 601.39M
- Revenue growth-15.5%
- Net incomeCNY 2.92M
- Free cash flowCNY 246.23M
- Gross margin30.4%
Valuation Snapshot
latest market cap is HKD 342.43M; P/E is 5.3.
Peer valuation comparison
Latest P/E is 5.32x versus a Healthcare sector median of 21.69x (75.5% below).
Latest P/E is 5.32x versus a China median of 16.26x (67.3% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 601.39M | CNY 2.92M | CNY 246.23M | 30.4% | n/a | CNY 1.52B | CNY 692.31M | CNY 1.16B |
| FY2024 | CNY 711.88M | -CNY 791.68M | CNY 228.38M | 29.6% | -1.33 | CNY 1.32B | CNY 1.07B | CNY 1.14B |
| FY2023 | CNY 891.50M | -CNY 102.26M | CNY 271.63M | 36.5% | -0.17 | CNY 1.24B | CNY 1.39B | CNY 2.11B |
| FY2022 | CNY 3.76B | CNY 377.31M | -CNY 180.27M | 34.8% | 0.66 | CNY 787.74M | CNY 786.12M | CNY 2.53B |
| FY2021 | n/a | n/a | n/a | n/a | 0.62 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 342.43M | 5.3 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 HKD.
| Year | Dividends/share |
|---|---|
| FY2024 | 0.02 CNY |
| FY2023 | 0.22 CNY |
| FY2022 | 0.09 CNY |
About Yunkang Group Limited
Yunkang Group Limited operates as a medical operation service provider in the People's Republic of China. The company offers diagnostic testing services for medical institution alliances, including setting up or upgrading diagnostic centers, the establishment of standard operating procedures for diagnostic testing, diagnostic consultation and staff training, procurement of equipment, smart internet of things, and logistics assistance. It also provides diagnostic outsourcing services comprising pathology tests;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Yunkang Group Limited's market cap?
Yunkang Group Limited's market capitalization is HKD 342.43M.
What is Yunkang Group Limited's P/E ratio?
Yunkang Group Limited's price-to-earnings (P/E) ratio is 5.3.
What does Yunkang Group Limited do?
Yunkang Group Limited operates as a medical operation service provider in the People's Republic of China. The company offers diagnostic testing services for medical institution alliances, including setting up or upgrading diagnostic centers, the establishment of standard operating procedures for diagnostic testing, diagnostic consultation and staff training, procurement of equipment, smart internet of things, and logistics assistance. It also provides diagnostic outsourcing services comprising pathology tests; infectious disease diagnostic tests; and genetic reproduction and screening tests.